Identification of a Novel Signaling Platform as a Cisplatin Target in Kidney Injury

Authors

Alice Lu University of Toledo Author https://orcid.org/0009-0007-5209-9347
Shay Soutari University of Toledo Author https://orcid.org/0009-0005-1311-0190
Mahasin A. Osman University of Toledo Author https://orcid.org/0000-0002-4331-2640

Research, chronic kidney disease, IQGAP1

Alice Lu, University of Toledo

Pre-med honors student interested in research
Shay Soutari, University of Toledo

Pre-med student who is interested in research.
Mahasin A. Osman, University of Toledo

Associate Professor
Departments of Medicine, Division of Oncology
College of Medicine and Life Sciences

2025-06-30

Dr. Lance D. Dworkin Department of Medicine Research Symposium

Authors who publish with this journal agree to the following terms:

Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License (CC BY 4.0) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).

Identification of a Novel Signaling Platform as a Cisplatin Target in Kidney Injury. Translation. 2025;13(S3). doi:10.46570/utjms-2025-1382

Download Citation